ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.405,20
0,51%
S&P 500
5.987,37
0,30%
Dow Jones
44.736,57
0,99%
Euro vs US Dollar
1,0459
-0,03%
Bitcoin
94.544,76
1,57%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) News

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PVCT
DatumZeitQuelleÜberschriftSymbolFirma
25/11/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/11/202414h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/11/202421h34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/10/202418h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/10/202402h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/10/202402h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/10/202401h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/10/202400h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/10/202400h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/09/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/08/202415h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
27/08/202417h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
19/08/202421h06Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/08/202401h23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/08/202401h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
13/08/202419h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/08/202421h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
05/08/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
23/07/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/07/202421h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
19/07/202419h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/07/202422h07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/07/202421h50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/06/202415h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/06/202412h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/06/202423h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/05/202423h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/05/202420h43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
13/05/202419h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202416h54Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

Kürzlich von Ihnen besucht

TG
TUI1
Tui
TG
D7G
Nel ASA
USOTC
BASFY
BASF (QX)
NYSE
JPM
JP Morgan Chase
FX
EURJPY
Euro vs Yen
TG
DTE
Deutsche Telekom
DBI
SDXP
SDAX
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
MDAX
MDAX
NASDAQ
GOOGL
Alphabet
COIN
XRPUSD
Ripple
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€